Application Note: WB: 1:2000. ICC/IF: 1:10-1:50. IHC-P: 1:25. FACS: 1:25. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 61
Form: Liquid
Buffer (with preservative): PBS, 0.09% sodium azide.
Concentration: Batch dependent (Please refer to the vial label for the specific concentration.)
Background: This gene encodes a tumor suppressor that is involved in transcriptional and post-transcriptional control pathways. The protein is a component of the the PAF protein complex, which associates with the RNA polymerase II subunit POLR2A and with a histone methyltransferase complex. This protein appears to facilitate the association of 3' mRNA processing factors with actively-transcribed chromatin. Mutations in this gene have been linked to hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism, and parathyroid carcinoma. [provided by RefSeq, Jul 2009]
Uniprot ID: Q6P1J9
Antigen Species: Human
Immunogen: KLH conjugated synthetic peptide between 132-161 amino acids from the Central region of human CDC73.
Purification: Protein A purified followed by antigen-affinity chromatography
Conjugation: Unconjugated
Full Name: cell division cycle 73